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The recent surge in viral clinical cases and associated neurological deficits have
reminded us that viral infections can lead to detrimental, long-term effects, termed
sequelae, in survivors. Alphaviruses are enveloped, single-stranded positive-sense RNA
viruses in the Togaviridae family. Transmission of alphaviruses between and within
species occurs mainly via the bite of an infected mosquito bite, giving alphaviruses
a place among arboviruses, or arthropod-borne viruses. Alphaviruses are found
throughout the world and typically cause arthralgic or encephalitic disease in infected
humans. Originally detected in the 1930s, today the major encephalitic viruses include
Venezuelan, Western, and Eastern equine encephalitis viruses (VEEV, WEEV, and
EEEV, respectively). VEEV, WEEV, and EEEV are endemic to the Americas and are
important human pathogens, leading to thousands of human infections each year.
Despite awareness of these viruses for nearly 100 years, we possess little mechanistic
understanding regarding the complications (sequelae) that emerge after resolution of
acute infection. Neurological sequelae are those complications involving damage to the
central nervous system that results in cognitive, sensory, or motor deficits that may
also manifest as emotional instability and seizures in the most severe cases. This article
serves to provide an overview of clinical cases documented in the past century as well
as a summary of the reported neurological sequelae due to VEEV, WEEV, and EEEV
infection. We conclude with a treatise on the utility of, and practical considerations for
animal models applied to the problem of neurological sequelae of viral encephalopathies
in order to decipher mechanisms and interventional strategies.
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INTRODUCTION
Alphaviruses are a genus of family Togaviridae. There are 29 recognized species of alphaviruses.
Alphaviruses are positive sense single-stranded RNA viruses that commonly cause febrile
illness followed by either encephalitic or arthralgic disease. Alphaviruses are grouped by the
composition of their antigenic complexes. At least eight antigenic complexes have been described
(Calisher et al., 1973, 1980; Boere et al., 1984; Greiser-Wilke et al., 1989; reviewed in Griffin,
2007). The arthralgic alphaviruses are designated Old World alphaviruses and include Sindbis
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virus (SINV), Chikungunya virus (CHIKV), and many other
members of the Semliki forest (SF) antigen complex. The
encephalitic viruses are characterized as New World alphaviruses
that have evolved separately from Old World alphaviruses
and include Venezuelan equine encephalitis virus (VEEV),
Eastern equine encephalitis virus (EEEV), and Western equine
encephalitis virus (WEEV) (Calisher et al., 1980; reviewed in
Griffin, 2007; Forrester et al., 2012; Voss et al., 2014).
The bite from an infected mosquito transmits alphaviruses
in the enzootic and epizootic cycles (Figure 1). Thus, the
species of mosquito varies for each alphavirus and determines
several aspects of the biology of transmission and etiology
of disease including the mechanism of viral maintenance in
natural reservoirs to the type of infection caused in humans
and other hosts (Kesler, 1933; Kubes and Rios, 1939; Suarez
and Bergold, 1968). Typically, infection with VEEV, WEEV, and
EEEV leads to a febrile illness following a 1–14 day incubation
period (CDC, 2012, 2013). Table 1 summarizes these virus-
specific epidemiological and clinical details. Currently, there are
no licensed vaccines in the United States, but live-attenuated
and formalin-inactivated version of VEEV, EEEV, and WEEV
have previously been used in the US military and laboratory
workers. However, 15–30% of vaccine recipients develop febrile
symptoms (Tigertt et al., 1962; McKinney et al., 1963; Alevizatos
et al., 1967; reviewed in Griffin, 2007). Unfortunately, there
are no specific therapeutic interventions; as such, clinicians are
limited to palliative care and supportive treatment for alphavirus-
infected patients.
Outbreak records and case reports from the past century
indicate that neurological sequelae are primarily associated
with VEEV, WEEV, and EEEV infection; although recent
studies report sensorineural hearing loss associated with CHIKV
infection (Rampal et al., 2007; Bhavana et al., 2008; Chusri et al.,
2011). Thanks to improved supportive therapy with modern
medical technology, many patients now survive the acute phase
of brain infection, yet go on to develop permanent neurological
sequelae that greatly reduce the quality of life of survivors and
their caregivers in addition to placing a high financial burden
on them and our healthcare system. For example, treatment
of one person suffering residual sequelae from EEEV costs
approximately $4.6M in lifetime care (Villari et al., 1995).
Even patients whose acute illness is relatively mild, frequently
have persistent movement disorders, cognitive complaints, and
functional disability (Mulder et al., 1951; Finley and Chapman,
1953; Fulton and Burton, 1953; Palmer and Finley, 1956; Hanson,
1957; Herzon et al., 1957; Bowen et al., 1976; Deaton et al., 1986).
Therefore, vaccines for prevention or interventions during or
post-acute illness could have significant impact on the quality of
life as well as on the healthcare cost.
CLINICAL CASES
The term ‘sequelae’ is broadly defined as a condition resultant
from previous disease. Neurological sequelae are those
complications involving the central nervous system (CNS)
FIGURE 1 | Transmission cycles of Venezuelan equine encephalitis viruses (VEEV), Western equine encephalitis viruses (EEEV), and Eastern equine
encephalitis viruses (WEEV). The virus naturally occurs in the enzootic cycle as it shifts between the animal host (rodent or bird) and the mosquito vector. Other
mosquitos can feed on infected animal hosts, thus transmitting the virus to humans, horses, and other large mammalian hosts, leading to an epizootic cycle.
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that include cognitive, sensory, and motor deficits that may
encompass emotional instability and seizure activity in the most
severe cases. Clinical case studies have documented that infection
with either VEEV, WEEV, or EEEV can cause severe neurological
sequelae, such as neuropsychological changes and intellectual
disabilities (Table 1). A variety of animal models exist to study
alphavirus encephalitis including mice, hamsters, guinea pigs,
rabbits, equines, and nonhuman primates (reviewed in Nalca
et al., 2003; Steele and Twenhafel, 2010; Zacks and Paessler,
2010). For each of these models, there are studies to describe
these animal models and the potentially associated viral and
immunological factors that could contribute to lethality and
neuroinvasion, but it is difficult to extrapolate the information
from these studies without knowing how these models would
present neurological sequelae. Human clinical cases are our
best documentation of neurological sequelae and the best
glimpse into potential mechanisms. Moreover, records for these
diseases in some areas of the world are incomplete and often
categorized with other similar diseases, so the human data is not
a true reflection of the incidence, severity, or characteristics of
alphavirus encephalitis. In fact, the World Health Organization
(WHO) does not track these diseases independently, but rather
refers to them as viral encephalitis, with a focus on West Nile
Virus and Japanese Encephalitis, making it difficult to establish
the full realm of cases with sequelae. Thus, limitations of the
clinical data further force us to depend on the large outbreak
cases described in the early 1950s, 60s, 70s, and 80s.
Venezuelan Equine Encephalitis
The number of cases of VEE reported each year is relatively low
compared to the other alphaviruses, although we would argue
this is a result of misdiagnosis of other arboviral encephalitis
agents. VEEV was first isolated in 1936 in equines (Kubes and
Rios, 1939) but it was not until the 1960s when human cases
occurred in various regions of Venezuela that the virus was
identified as the cause of human disease. Little data is available
regarding the neurological complications of these original cases,
but studies at the time were able to confirm the role of Aedes
mosquitos in transmitting the virus in Venezuelan urban areas
(Suarez and Bergold, 1968). Although the Centers for Disease
Control and Prevention (CDC) have documented cases of VEEV
infection in the US, little information is available beyond case
numbers and deaths. For example, in 1971, a VEEV outbreak
occurred in Texas that reported 86 hospital-based surveillance
cases. Forty-eight of the 86 cases reported follow up nine months
to one year after recovery. Of these, 12 cases were confirmed to
present with long-lasting neurological sequelae occurring months
after the clearance of the acute infection. In these cases, sequelae
included paralysis, reductions in hearing, taste, and smell, as well
as recurrent headaches, severe fatigue, and depression (Bowen
et al., 1976). In 1995, a large outbreak occurred in Columbia,
leaving 75,000 infected, 300 dead, and 3,000 with neurological
complications. Seizures and neuropsychological changes were
common among those with neurological complications (Rivas
et al., 1997). More recently, in 2010, a Panamanian VEEV
outbreak occurred alongside EEEV, during which 11 confirmed
cases of VEE were reported, four of which experienced long-term
sequelae. Although these patients were young males (between
the ages of 3–18) and spent less than one week in the hospital,
three patients suffered altered mental status and one experienced
seizures (Carrera et al., 2013). In spite of VEE being historically
underreported, we cannot rule it out as a large contributor to
human encephalitic disease with resultant sequelae.
Western Equine Encephalitis
Similar to VEEV, WEEV was first isolated in 1930 (Meyer et al.,
1931) and Culex mosquito transmission was confirmed in 1933
(Kesler, 1933). Between 1964 and 2010, 640 cases of WEE were
reported in the United States by the CDC (2010). Cases have
dwindled over the past few years for as yet to be determined
reasons, but a drop in viral virulence is not considered to underlie
this trend (Forrester et al., 2008). Although the mortality rate for
WEE is low, upwards of 30% of infections develop neurological
sequelae. As such, WEE cases provide us with the majority
of clinical data regarding sequelae. This can provide insight
into common mechanisms between the three closely related
encephalitic alphaviruses.
Between 1939 and 1956, there were 636 recorded cases of WEE
in the United States and Canada, of which 86 cases had sequelae.
The sequelae included brain damage leading to quadriplegia,
TABLE 1 | Encephalitic alphaviruses.
Venezuelan encephalitis viruses
(VEEV)
Western encephalitis viruses
(WEEV)
Eastern equine encephalitis
viruses (EEEV)
Transmission Rodents, mosquitos (Aedes, Culex,
Psorophora etc.)
Birds, mosquitos (Aedes, Culex, etc.) Rodents/birds, mosquito (Aedes,
Culiesta, etc.)
Average incubation time 1–5 days 2–7 days 3–10 days
Initial symptoms Asymptomatic, febrile illness Asymptomatic, febrile illness Asymptomatic, febrile illness
Clinical syndrome Encephalitis Encephalitis Encephalitis
Case-fatality (%) 1 3–7 50–75
Associated neurological sequelae Convulsions, somnolence, confusion,
photophobia, coma, intellectual
disability, and emotional
instability/behavioral changes
Confusion, visual disturbances,
photophobia, seizures, somnolence,
coma, intellectual disability, and
emotional instability/behavioral
changes, and spastic paresis
Convulsions, seizures, paralysis,
intellectual disability, and behavioral
changes
% Survivors with neurological sequelae 4–14 15–30 50–90
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hemiplegia, and intellectual disability. The frequency of these
sequelae in children under one year of age was greater than
50%. In adults, a Parkinson-like disease was reported, as well
as schizophrenia-like personality changes (Herzon et al., 1957).
Fifteen of these cases from the 1949 outbreak were followed for
6–8 months after acute illness recovery (Mulder et al., 1951) and
the 1952 epidemic of viral encephalitis including both WEE and
St Louis Encephalitis in California (Palmer and Finley, 1956).
In both outbreaks, patients were evaluated by a psychiatrist
and subjected to age-specific psychological and cognitive tests.
Seizures, decreased motor skills, intellectual disability, learning
disabilities, speech difficulty, psychological impairment, altered
gait, taste distortion, and loss of facial movements were reported
in children and adults although both studies concluded higher
incidence of sequelae in children (Mulder et al., 1951; Palmer and
Finley, 1956). Interestingly, Palmer et al. noticed that children
under 3 months of age seemingly recovered from the sequelae
over time, but these children then experienced similar sequelae
months or years following the described recovery (Palmer and
Finley, 1956).
Similar to the findings of Palmer, Mulder, and Herzon,
another research group performed a follow up study for a
Texas outbreak that included 35 WEEV cases between 1963
and 1966 (Earnest et al., 1971). Follow up occurred 2–7 years
after acute infection. Of the 22 cases available for follow
up, 12 children and 3 adults had measurable sequelae. The
researchers divided the sequelae into three categories based on
psychological and cognitive sequelae. The majority of patients
(seven) experienced intellectual disability, seizures, and spastic
weakness, one had hearing and speech deficit, and four had
minimal brain dysfunction, such as attention deficit disorder
(Earnest et al., 1971). This distribution of sequelae is typical for
these alphaviruses.
Interestingly, two separate case studies twenty years apart
describe overlapping sequelae. In 1962, Cohn and Kuida
described the case of a 43-year old male infected with WEEV
who previously had no respiratory symptoms. After infection, he
developed primary alveolar hypoventilation, a very rare condition
that can be due to damaged motor neurons (Cohn and Kuida,
1962). In 1981, a 17 year-old male recently infected with WEEV
was found to have the same symptoms and diagnosis. In this case,
the young male also developed sleep apnea. His condition was
treatable with chemical stimuli and over a period of 3 to 4 months
his condition improved (White et al., 1983).
Arguably, the most devastating of the sequelae are those
related to severe neuropsychological changes. Depression,
anxiety, paranoia, and decreased intellectual abilities were present
in many of the cases discussed above (Mulder et al., 1951; Palmer
and Finley, 1956; Herzon et al., 1957). A psychological study
of alphavirus patients in Canada (Fulton and Burton, 1953) led
researchers to conclude that psychological patients in hospital
facilities may be suffering the sequelae of alphavirus encephalitis,
yet were wrongly diagnosed with psychiatric disorders since these
patients were unresponsive to conventional treatments for their
diagnoses. Tests in two institutional hospitals supported this
concept, as 36 of the patients tested were confirmed to have
WEEV antibodies, while seven additional patients were suspected
to have had viral encephalitis, although antibody tests were
inconclusive (Fulton and Burton, 1953).
A particularly devastating example of misdiagnosis emanates
from a 1986 case report from Deaton and colleagues followed the
case of a 22-year-old female psychiatric patient, later determined
to be the sequelae of an encephalitic infection. The patient
presented with psychotic and neuropsychological symptoms,
such as severe mood swings, paranoia, generalized confusion, and
decreased ability to perform daily tasks, including her job as a
cashier. Her family had her evaluated by a psychiatrist under the
belief that her symptoms were related to emotional stress. The
psychiatrist diagnosed her as “acutely psychotic” and had her
institutionalized. Initially, she was treated with phenothiazines,
which target G-protein coupled receptors such as dopamine
and andregenic receptors, and electroconvulsive shock therapy,
which alters the brain chemistry. Rapidly, the patient’s condition
deteriorated to self-mutilation and muteness, leading to a
diagnosis of schizophrenia. Following transfer to a new facility at
which she received a complete neurological evaluation including
CT scans, evoked potentials, lumbar punctures, brain biopsy of
the right frontal lobe, EEGs, and an Amytal interview. The brain
biopsy indicated some signs of encephalitis, but was considered
inconclusive. The Amytal interview reflected decompensation
and disorientation, a profile typical of encephalitis patients
with neurological sequelae. It was only after these tests that
the doctors re-considered the importance of the death of her
horse from equine encephalitis shortly prior to the onset of
her neuropsychological symptoms. The patient was eventually
diagnosed with infectious encephalitis. With time, her speech
returned, but her condition did not generally improve (Deaton
et al., 1986). This unfortunate case exemplifies the need for
early detection and treatment of encephalitis as well as rapid
and proper diagnosis of sequelae. Today, we can only hope
that improved detection standards for these viruses will aid in
preventing such tragic outcomes.
Eastern Equine Encephalitis
The first recorded epidemic of EEE was in horses of
Massachusetts in 1831 (Hanson, 1957); however, the virus
was not isolated and named until 1933 (Tenbroeck and Merrill,
1933). EEE is considered the most deadly of the three major
encephalitic alphaviruses, with a case-fatality rate of 50–75%
(CDC, 2010). It is therefore not surprising that the following
case studies describe up to 90% of survivors as developing
sequelae. In the United States alone, approximately 285
confirmed cases of EEE have been documented since 1964
(CDC, 2012, 2013). Of the 15 EEE cases reported in New
Hampshire and Massachusetts children between 1970 and 2010,
seven of these cases were associated with mental disability,
with only four of those cases improving. Although these case
reports do not describe the specific sequelae or categorize
the mental disabilities encountered, it does provide us with
incidence data and the potential frequency that neurological
sequelae revert to normal (Silverman et al., 2013). Without
specific treatment data, determination of the mechanisms that
led to symptomatic improvement in these four cases is not
possible.
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Resulting from a fatal case of EEE, Reddy and colleagues
in 2008 published autopsy findings that the patient had severe
neuronal loss and gliosis of the dorsal motor nucleus that likely
led to death from multiple organ failure (Reddy et al., 2008), as
the dorsal motor nucleus is a key player in the parasympathetic
system of the autonomic nervous system (Kumar et al., 2010).
This study reinforces the necessity of autopsies performed on
patients that succumb to viral encephalopathies to provide
additional mechanistic information to be further studied in
animal models.
A recent Panama outbreak of EEE/VEE in 2010 recorded 99
acute infection cases, where eight patients 1–13 years of age
experienced neurological sequelae. The most common sequelae
were seizures, which initially occurred in 63% of patients. Brain
imaging was performed on these patients, and abnormalities
were seen in the temporal lobe (Carrera et al., 2013). The
temporal lobe is important for the establishment of and storage
of new memories and their integration with emotion, language,
and sensory processing (Kumar et al., 2010), thus providing
a potential explanation for the types of neurological sequelae
observed in this outbreak.
Summary of Sequelae
As noted above, the severity of alphavirus-induced sequelae can
vary from manageable learning disabilities to life altering and life
threatening psychosis. Sequelae is most commonly described in
children, but can affect individuals of any age group regardless of
the severity of the febrile illness. The most detrimental cases of
long term alphavirus sequelae seem to occur post encephalitis.
WEEV has the most documented sequelae, with up the 90%
of survivors developing long-term complication, while up to
75% of EEEV and 14% of VEEV survivors describe the same
syndromes.
Interestingly, these sequelae are similar to what has been
described for other arboviruses, such as the flaviviruses.
Cognitive deficits and behavior changes are described for
Japanese encephalitis virus (JEV) and West Nile Virus
(WNV). Decreased memory and learning and behavior
impairments have been reported post-JEV infection, with
one study identifying that 2 years post infection 78% of
survivors maintained memory and learning deficits and
47% still have behavioral impairments (Das and Basu, 2008;
Hossain et al., 2010; Kakoti et al., 2013; Yin et al., 2015).
In fact, a rat model of JEV replicated this memory and
learning deficit post-infection (Chauhan et al., 2016). However,
unlike in human cases, this deficit in the rat model was only
transient.
West Nile Virus studies provide valuable information about
neurological sequelae post-viral infections using more recent
observational studies. Neurological sequelae of WNV are similar
to what is described to JEV and the alphaviruses, with individuals
experiencing cognitive and behavioral changes (Asnis et al.,
2000; Madden, 2003; Burton et al., 2004; Klee et al., 2004;
Gottfried et al., 2005; LaBeaud et al., 2006; Hart et al., 2014;
Murray et al., 2014; Morjaria et al., 2015; Patel et al., 2015;
Weatherhead et al., 2015; Anukumar et al., 2016; Winkelmann
et al., 2016). Evaluations of the Houston West Nile Cohort
described that even 8 years after infection, approximately 40% of
survivors continued to experience some sort of sequelae (Murray
et al., 2014; Weatherhead et al., 2015). Unlike the alphaviruses,
WNV has also been described to lead to visual impairment and
retinopathy, balance problems, hearing loss, and joint problems
(Asnis et al., 2000; Burton et al., 2004; Gottfried et al., 2005;
LaBeaud et al., 2006; McBride et al., 2006; Casetta et al., 2011;
Hart et al., 2014; Murray et al., 2014; Weatherhead et al., 2015;
Anukumar et al., 2016; Hasbun et al., 2016; Winkelmann et al.,
2016).
Economic Burden
Not only can these complications be detrimental to health,
these conditions can lead to complex health economics. When
Earnest et al. evaluated sequelae of the Texas WEE outbreak
in 1971, they also determined the cost of infection per
person at $320,000 (Earnest et al., 1971). More than twenty
years later, Villari et al. (1995) determined the economic
burden associated with patients suffering long-term sequelae
due to EEE. Overall hospital costs for the first week of
infection were determined by Villari and colleagues to be
approximately $21,000. For someone suffering from long-
term sequelae, medical costs would exceed $0.4 million per
year per individual, with costs reaching up to $3 million
in the life span of the affected individual. This estimate
does not cover the cost of institutionalization for individuals
that do not have dedicated caregivers. At the time this was
calculated, the cost of insecticidal prevention of mosquito
vectors ranged from $0.7 to $1.4 million dollars. Although
large outbreaks of these diseases are uncommon today, the
potential still exists and the economic consequences could prove
disastrous.
APPLYING NEUROSCIENCE TO VIRAL
SEQUELAE
As discussed above, long-term neurological sequelae are common
among survivors of the three major encephalitic alphavirus
infections. Neurological sequelae are those complications
involving the brain that include cognitive, sensory, and motor
deficits that may encompass emotional instability and seizure
activity in the most severe cases. Unfortunately, little is known
regarding susceptibility to, prevention of, or treatment for
neurological sequelae resulting from alphavirus encephalitis.
Studies using preclinical models are needed to establish
mechanisms of infiltration or involvement of the CNS in
neurological sequelae.
Well-established murine models are available to study each
of these virus’ initial infection (Nalca et al., 2003; Paessler
et al., 2004, 2006, 2007; Carrara et al., 2005; Steele and
Twenhafel, 2010; Zacks and Paessler, 2010; Taylor et al.,
2011, 2012) Behavioral platforms are also available to study
neurological sequelae in mice, such as the SHIRPA battery for
phenotypic assessment of neurological function, acoustic startle
in the prepulse inhibition (PPI) paradigm, cued and contextual
fear conditioning. Given the many years of clinical data in
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humans for each of these viruses and the murine models that
closely mimic human diseases, we propose that neurological
sequelae following acute viral infection can be detected in
murine models for alphaviruses, providing a tool to study
the mechanistic causes of these sequelae. We further propose
that murine models can provide insights into the devastating
neurological sequelae of life-threatening alphavirus encephalitis
to identify therapeutic strategies to reverse or prevent post-acute-
disease complications and improve the overall quality of life of
survivors.
SHIRPA
The SHIRPA battery for phenotypic assessment of neurological
function is a general screen that quantitatively evaluates the
animal’s behavior. The behavior is analyzed is three stages;
the primary, secondary, and tertiary screens (Rogers et al.,
1997). The primary screen is based on a screen developed
by Irwin and colleagues in 1968 which evaluates defects in
areas such as the animal’s gait, motor control, coordination,
and muscle tone. These areas are scored with the SHIRPA
protocol for quantitative analyses that can be compared over
time and between groups. The secondary screen measures
locomotor activity, food and water intake, balance and
coordination, analgesia, histology, and biochemistry. Many
of these tests are carried out with behavioral equipment,
such as the rota-rod for balance and coordination, and do
not require a scale rating for quantitative measures. These
first two screens can be used to evaluate the phenotype
for a wide range of applications, but the tertiary screen is
designed to address neurological mutants. This final screen
evaluates anxiety, learning and memory, PPI, electromyography,
electroencephalography, nerve conduction, and magnetic
resonance imaging (Rogers et al., 1997). The SHIRPA evaluation
performed can be adapted to meet the needs of the study,
and not all the steps described here are required. This is
an excellent evaluation for use in preliminary evaluation of
animal models for viral sequelae studies, as it can identify
basic problems related to the brain and musculature without
the need for expensive equipment. Additionally, many of
the steps associated with SHIRPA are easily performed
with little training and are easily adaptable to various
biocontainment facilities with the use of proper animal
handling techniques.
Acoustic Startle Reflex (ASR)
The startle response is an involuntary reaction elicited by an
unexpected sound stimulus (Swerdlow et al., 1999). This reflex
circuit begins in the cochlear nuclei of the brainstem where
the acoustic startle stimulus is communicated to the caudal
pontine reticular nucleus before impinging upon the motor
neurons within the dorsal spinal cord to elicit a motor response
(Davis et al., 1982b; Koch and Schnitzler, 1997; Koch, 1999;
Fendt et al., 2001) (Figure 2). The acoustic startle threshold
is the minimum decibel level that results in a flinch. Deaf
animals do not flinch until the tone is 120 dB or above,
likely responding to vibrations they sense through touching
the equipment and not the sound itself (Crawley, 2007). Thus,
intact hearing is crucial to successful measurements of both
ASR and PPI; therefore, the SHIRPA evaluation is key to
perform as an initial measure of neurological function. This
is very important to keep in mind for viruses that may cause
hearing loss or impairment on top of other neurological sequelae,
such as West Nile virus (McBride et al., 2006; Casetta et al.,
2011).
Several aspects of the startle response can be measured to
determine changes in neurological processing and sensorimotor
gating, such as latency of the response and the peak value
of the motor response (Davis et al., 1982a,b). The latency
is a measure of neural processing speed, or the time that
it takes for the sound stimulus to elicit a motor response,
while the peak value of the motor responses measures the
intensity of the motor response. ASR has been used to study
outcomes of infections with other disease. For example, infection
with Toxoplasma gondii leads to a decreased-acoustic startle
latency. T. gondii is an obligate intracellular protozoan that
typically causes an asymptomatic infection in healthy individuals,
but chronic infections leads to the development of cysts
in the muscles and brain (Pearce et al., 2013). Evaluating
these aspects of the startle response can provide a general
overview of problems caused by encephalitic viruses post-
infection.
Prepulse Inhibition
Prepulse inhibition is an extension of the ASR that falls
under the umbrella of sensorimotor gating paradigms. Basic
PPI involves delivery of a low dB stimulus, the prepulse
(between 3 and 12 dB above background), that is followed
within 100 ms by a second higher db stimulus (Figure 2).
Because of the temporal pairing of the prepulse with the
main acoustic stimulus, the acoustic startle pathway is occupied
leading to divergence of the sound stimulus through an alternate
neural circuit that involves midbrain regions that results in
feedback inhibition on motor neurons that decreases the motor
response compared to the flinch response elicited in the absence
of a prepulse (Kohl et al., 2013) (Figure 2). PPI deficits
are well characterized in schizophrenias (Braff et al., 1978,
2001; Braff, 1992; Grillon et al., 1992; Kumari et al., 1999;
Weike et al., 2000), obsessive compulsive disorder (Ahmari
et al., 2012; Kohl et al., 2013) and Gilles de la Tourette’s
syndrome (Castellanos et al., 1996; Swerdlow et al., 2001;
Kohl et al., 2013). Patients with bipolar disorder also have
detectable state-dependent PPI and sensorimotor gating deficits
(Barrett et al., 2005; Rich et al., 2005; Carroll et al., 2007;
Kohl et al., 2013). Several of these behavioral problems have
been described in alphavirus survivors described above, as well
as flavivirus infection, thus confirming the value of PPI as
a tool to quantitatively measure the presence of neurological
sequelae.
Methods of Hearing Evaluation
In addition to the SHIRPA, a basic way to test hearing
is with a clicker, a very small plastic box with a metal
strip that makes a click sound when pressed. When testing
hearing, a single click should result in an ear flick, jump,
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FIGURE 2 | Acoustic startle and prepulse inhibition pathways. The pathway that the sound stimulus travels during acoustic startle reflex (ASR; green) and
prepulse inhibition (PPI; purple). In the ASR circuit, the sound stimulus travels from the cochlear nuclei to the caudal pontine reticular nucleus (PnC) where it transmits
the sound to the motor neurons and leads to a motor response, such as a jump or twitch. In the PPI circuit, a less intense acoustic stimulus, termed “prepulse”, is
played within 100 ms prior to the startle stimulus. Since the portion of the ASR pathway (green) is preoccupied with the prepulse stimulus, the sound is forced to
travel a different route (purple) to the PnC and motor neurons, which leads to a decreased motor response to the acoustic stimulus.
or brief head motionlessness (Crawley, 2007). Repeated clicks
are considered ineffective. Should the ASR or PPI response
change and the animal no longer responds normally to
the clicker, additional tests should be done to evaluate the
auditory threshold of the animal. These tests will be especially
important to viral infections that are known to lead to
hearing loss, such as WNV (McBride et al., 2006; Casetta
et al., 2011; Anukumar et al., 2016). Two such tests are
measurements of otoacoustic emissions (OAE) and auditory-
evoked brainstem response (ABR). Conveniently, ASR, PPI,
OAE, and ABR are tests available for both humans and rodent
models, allowing for an easier transition into translational
research.
CONCLUSION
As we learn more about the basics of disease infection and
proliferation, it is important to apply this knowledge and bring
together techniques of other fields for a broader application
of animal models to human disease. Currently, no one has
evaluated the long-term sequelae of alphaviral encephalitis using
the available animal models of acute infection. Exploration
of cognitive changes in infected mice or another relevant
rodent model has the potential to educate us about the
sequelae in humans and allow to the delineation of mechanisms
directly associated with sequelae. Utilizing preclinical models
for alphavirus encephalitis and neurological sequelae requires
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BSL3-BSL4 facilities, which imposes logistic challenges for
performing the types of exams and tests described above. These
obstacles can be overcome with interdisciplinary training and
assistance from environmental health and safety officers to
develop a much needed small animal model. Such an animal
model that allows for cognitive evaluation would also present
an opportunity to study prevention of sequelae with vaccination,
as the cost of a vaccine that prevents infection and long-term
sequelae would outweigh the millions of dollars of medical
resources required to treat one patient.
AUTHOR CONTRIBUTIONS
All authors listed, have made substantial, direct and intellectual
contribution to the work, and approved it for publication.
FUNDING
SER is currently funded by the Institute for Translational Sciences
at the University of Texas Medical Branch, supported in part by a
Clinical and Translational Science Award NRSA (TL1) Training
Core (TL1TR001440) from the National Center for Advancing
Translational Sciences, National Institutes of Health.
ACKNOWLEDGMENTS
The authors would like to acknowledge the Department of
Neuroscience and Cell Biology, the Center for Addiction
Research, and the Institute for Human Infections and Immunity
at the University of Texas Medical Branch for previous funding
support for SER.
REFERENCES
Ahmari, S. E., Risbrough, V. B., Geyer, M. A., and Simpson, H. B. (2012). Impaired
sensorimotor gating in unmedicated adults with obsessive-compulsive disorder.
Neuropsychopharmacology 37, 1216–1223. doi: 10.1038/npp.2011.308
Alevizatos, A. C., McKinney, R. W., and Feigin, R. D. (1967). Live, attenuated
Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man.
Am. J. Trop. Med. Hyg. 16, 762–768.
Anukumar, B., Thekkekara, R. J., and Tandale, B. V. (2016). Outcomes of West Nile
encephalitis patients after one year of West Nile encephalitis outbreak in Kerala,
India: a follow-up study. J. Med. Virol. doi: 10.1002/jmv.24545 [Epub ahead of
print].
Asnis, D. S., Conetta, R., Teixeira, A. A., Waldman, G., and Sampson, B. A. (2000).
The west nile virus outbreak of 1999 in New York: the Flushing Hospital
experience. Clin. Infect. Dis. 30, 413–418. doi: 10.1086/313737
Barrett, S. L., Kelly, C., Watson, D. R., Bell, R., and King, D. J. (2005). Normal levels
of prepulse inhibition in the euthymic phase of bipolar disorder. Psychol. Med.
35, 1737–1746. doi: 10.1017/S0033291705005702
Bhavana, K., Tyagi, I., and Kapila, R. K. (2008). Chikungunya virus induced sudden
sensorineural hearing loss. Int. J. Pediatr. Otorhinolaryngol. 72, 257–259. doi:
10.1016/j.ijporl.2007.09.022
Boere, W. A., Harmsen, T., Vinje, J., Benaissa-Trouw, B. J., Kraaijeveld, C. A., and
Snippe, H. (1984). Identification of distinct antigenic determinants on Semliki
Forest virus by using monoclonal antibodies with different antiviral activities.
J. Virol. 52, 575–582.
Bowen, G. S., Fashinell, T. R., Dean, P. B., and Gregg, M. B. (1976). Clinical aspects
of human Venezuelan equine encephalitis in Texas. Bull. Pan Am. Health
Organ. 10, 46–57.
Braff, D., Stone, C., Callaway, E., Geyer, M., Glick, I., and Bali, L. (1978).
Prestimulus effects on human startle reflex in normals and schizophrenics.
Psychophysiology 15, 339–343. doi: 10.1111/j.1469-8986.1978.tb01390.x
Braff, D. L. (1992). Reply to cognitive therapy and schizophrenia. Schizophr. Bull.
18, 37–38. doi: 10.1093/schbul/18.1.37
Braff, D. L., Geyer, M. A., Light, G. A., Sprock, J., Perry, W., Cadenhead,
K. S., et al. (2001). Impact of prepulse characteristics on the detection of
sensorimotor gating deficits in schizophrenia. Schizophr. Res. 49, 171–178. doi:
10.1016/S0920-9964(00)00139-0
Burton, J. M., Kern, R. Z., Halliday, W., Mikulis, D., Brunton, J., Fearon, M., et al.
(2004). Neurological manifestations of West Nile virus infection. Can. J. Neurol.
Sci. 31, 185–193. doi: 10.1017/S0317167100053828
Calisher, C. H., Sasso, D. R., and Sather, G. E. (1973). Possible evidence for
interference with Venezuelan equine encephalitis virus vaccination of equines
by pre-existing antibody to Eastern or Western Equine encephalitis virus, or
both. Appl. Microbiol. 26, 485–488.
Calisher, C. H., Shope, R. E., Brandt, W., Casals, J., Karabatsos, N., Murphy,
F. A., et al. (1980). Proposed antigenic classification of registered arboviruses
I. Togaviridae Alphavirus. Intervirology 14, 229–232. doi: 10.1159/000149190
Carrara, A. S., Gonzales, G., Ferro, C., Tamayo, M., Aronson, J., Paessler, S.,
et al. (2005). Venezuelan equine encephalitis virus infection of
spiny rats. Emerg. Infect. Dis. 11, 663–669. doi: 10.3201/eid1105.
041251
Carrera, J. P., Forrester, N., Wang, E., Vittor, A. Y., Haddow, A. D., Lopez-
Verges, S., et al. (2013). Eastern equine encephalitis in Latin America. N. Engl.
J. Med. 369, 732–744. doi: 10.1056/NEJMoa1212628
Carroll, C. A., Vohs, J. L., O’Donnell, B. F., Shekhar, A., and Hetrick,
W. P. (2007). Sensorimotor gating in manic and mixed episode bipolar
disorder. Bipolar Disord. 9, 221–229. doi: 10.1111/j.1399-5618.2007.
00415.x
Casetta, I., Ciorba, A., Cesnik, E., Trevisi, P., Tugnoli, V., and Bovo, R. (2011).
West Nile virus neuroinvasive disease presenting with acute flaccid paralysis
and bilateral sensorineural hearing loss. J. Neurol. 258, 1880–1881. doi:
10.1007/s00415-011-6011-3
Castellanos, F. X., Fine, E. J., Kaysen, D., Marsh, W. L., Rapoport, J. L., and
Hallett, M. (1996). Sensorimotor gating in boys with Tourette’s syndrome
and ADHD: preliminary results. Biol. Psychiatry 39, 33–41. doi: 10.1016/0006-
3223(95)00101-8
CDC (2010). Arboviral Encephalitis Cases Reported in
Humans by Virus, United States, 1964-2010. Available at:
http://www.cdc.gov/ncidod/dvbid/arbor/arbocase.htm-content_area
CDC (2012). West nile virus disease and other arboviral diseases, United States,
2011. MMWRMorb. Mortal. Wkly. Rep. 61, 510–514.
CDC (2013). West nile virus disease and other arboviral diseases, United States,
2011. MMWRMorb. Mortal. Wkly. Rep. 62, 513–517.
Chauhan, P. S., Misra, U. K., Kalita, J., Chandravanshi, L. P., and Khanna,
V. K. (2016). Memory and learning seems to be related to cholinergic
dysfunction in the JE rat model. Physiol. Behav. 156, 148–155. doi:
10.1016/j.physbeh.2016.01.006
Chusri, S., Siripaitoon, P., Hirunpat, S., and Silpapojakul, K. (2011). Case reports of
neuro-Chikungunya in southern Thailand. Am. J. Trop. Med. Hyg. 85, 386–389.
doi: 10.4269/ajtmh.2011.10-0725
Cohn, J. E., and Kuida, H. (1962). Primary alveolar hypoventilation associated with
Western equine encephalitis. Ann. Intern. Med. 56, 633–644. doi: 10.7326/0003-
4819-56-4-633
Crawley, J. N. (2007). What’s Wrong with My Mouse: Behavioral Phenotyping of
Transgenic and Knockout Mice. Hoboken, NJ: John Wiley & Sons, Inc.
Das, S., and Basu, A. (2008). Japanese encephalitis virus infects neural progenitor
cells and decreases their proliferation. J. Neurochem. 106, 1624–1636. doi:
10.1111/j.1471-4159.2008.05511.x
Davis, M., Gendelman, D. S., Tischler, M. D., and Gendelman, P. M. (1982a).
A primary acoustic startle circuit: lesion and stimulation studies. J. Neurosci.
2, 791–805.
Davis, M., Parisi, T., Gendelman, D. S., Tischler, M., and Kehne, J. H. (1982b).
Habituation and sensitization of startle reflexes elicited electrically from the
brainstem. Science 218, 688–690. doi: 10.1126/science.7134967
Frontiers in Microbiology | www.frontiersin.org 8 June 2016 | Volume 7 | Article 959
fmicb-07-00959 June 16, 2016 Time: 13:1 # 9
Ronca et al. Alphavirus Sequelae
Deaton, A. V., Craft, S., and Skenazy, J. (1986). Enduring psychiatric and
neuropsychologic sequelae in the post-encephalitis patient. Int. J. Psychiatry
Med. 16, 275–280. doi: 10.2190/RV2Q-UKFW-UY9L-5D8H
Earnest, M. P., Goolishian, H. A., Calverley, J. R., Hayes, R. O., and Hill, H. R.
(1971). Neurologic, intellectual, and psychologic sequelae following western
encephalitis. A follow-up study of 35 cases. Neurology 21, 969–974. doi:
10.1212/WNL.21.9.969
Fendt, M., Li, L., and Yeomans, J. S. (2001). Brain stem circuits mediating prepulse
inhibition of the startle reflex. Psychopharmacology (Berl.) 156, 216–224. doi:
10.1007/s002130100794
Finley, K. H., and Chapman, W. M. (1953). The 1952 outbreak of encephalitis in
California; long term neurologic and psychiatric studies of sequelae. Calif. Med.
79, 94–96.
Forrester, N. L., Kenney, J. L., Deardorff, E., Wang, E., and Weaver, S. C.
(2008). Western Equine Encephalitis submergence: lack of evidence for a
decline in virus virulence. Virology 380, 170–172. doi: 10.1016/j.virol.2008.
08.012
Forrester, N. L., Palacios, G., Tesh, R. B., Savji, N., Guzman, H., Sherman, M.,
et al. (2012). Genome-scale phylogeny of the alphavirus genus suggests a marine
origin. J. Virol. 86, 2729–2738. doi: 10.1128/JVI.05591-11
Fulton, J. S., and Burton, A. N. (1953). After effects of western equine
encephalomyelitis infection in man. Can. Med. Assoc. J. 69, 268–272.
Gottfried, K., Quinn, R., and Jones, T. (2005). Clinical description and follow-up
investigation of human West Nile virus cases. South Med. J. 98, 603–606. doi:
10.1097/01.SMJ.0000155633.43244.AC
Greiser-Wilke, I., Moenning, V., Kaaden, O. R., and Figueiredo, L. T. (1989). Most
alphaviruses share a conserved epitopic region on their nucleocapsid protein.
J. Gen. Virol. 70(Pt 3), 743–748. doi: 10.1099/0022-1317-70-3-743
Griffin, D. E. (2007). “Alphaviruses,” in Fields Virology, eds D. L. Knipe, P. M.
Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, et al.
(Philadelphia, PA: Lippincott Williams & Wilkins), 1001–1067.
Grillon, C., Ameli, R., Charney, D. S., Krystal, J., and Braff, D. (1992). Startle
gating deficits occur across prepulse intensities in schizophrenic patients. Biol.
Psychiatry 32, 939–943. doi: 10.1016/0006-3223(92)90183-Z
Hanson, R. P. (1957). An epizootic of equine encephalomyelitis that occurred in
Massachusetts in 1831. Am. J. Trop. Med. Hyg. 6, 858–862.
Hart, J. Jr., Tillman, G., Kraut, M. A., Chiang, H. S., Strain, J. F., Li, Y., et al.
(2014). West Nile virus neuroinvasive disease: neurological manifestations and
prospective longitudinal outcomes. BMC Infect. Dis. 14:248. doi: 10.1186/1471-
2334-14-248
Hasbun, R., Garcia, M. N., Kellaway, J., Baker, L., Salazar, L., Woods, S. P.,
et al. (2016). West nile virus retinopathy and associations with long term
neurological and neurocognitive sequelae. PLoS ONE 11:e0148898. doi:
10.1371/journal.pone.0148898
Herzon, H., Shelton, J. T., and Bruyn, H. B. (1957). Sequelae of western
equine and other arthropod-borne encephalitides. Neurology 7, 535–548. doi:
10.1212/WNL.7.8.535
Hossain, M. J., Gurley, E. S., Montgomery, S., Petersen, L., Sejvar, J., Fischer, M.,
et al. (2010). Hospital-based surveillance for Japanese encephalitis at four
sites in Bangladesh, 2003-2005. Am. J. Trop. Med. Hyg. 82, 344–349. doi:
10.4269/ajtmh.2010.09-0125
Kakoti, G., Dutta, P., Ram Das, B., Borah, J., and Mahanta, J. (2013).
Clinical profile and outcome of Japanese encephalitis in children admitted
with acute encephalitis syndrome. Biomed Res. Int. 2013, 152656. doi:
10.1155/2013/152656
Kesler, R. A. (1933). Mosquitoes as vectors of the virus of equine encephalomyelitis.
J. Am. Vet. Med. Assoc. 82, 767–771.
Klee, A. L., Maidin, B., Edwin, B., Poshni, I., Mostashari, F., Fine, A., et al. (2004).
Long-term prognosis for clinical West Nile virus infection. Emerg. Infect. Dis.
10, 1405–1411. doi: 10.3201/eid1008.030879
Koch, M. (1999). The neurobiology of startle. Prog. Neurobiol. 59, 107–128. doi:
10.1016/S0301-0082(98)00098-7
Koch, M., and Schnitzler, H. U. (1997). The acoustic startle response in rats–circuits
mediating evocation, inhibition and potentiation. Behav. Brain Res. 89, 35–49.
doi: 10.1016/S0166-4328(97)02296-1
Kohl, S., Heekeren, K., Klosterkotter, J., and Kuhn, J. (2013). Prepulse inhibition in
psychiatric disorders–apart from schizophrenia. J. Psychiatr. Res. 47, 445–452.
doi: 10.1016/j.jpsychires.2012.11.018
Kubes, V., and Rios, F. A. (1939). The causative agent of infectious
equine encephalomyelitis in Venezuela. Science 90, 20–21. doi:
10.1126/science.90.2323.20
Kumar, V., Abbas, A. K., Fausto, N., and Aster, J. C. (2010). Pathologic Basis of
Disease. Philadelphia, PA: Saunders, Elsevier Inc.
Kumari, V., Soni, W., and Sharma, T. (1999). Normalization of information
processing deficits in schizophrenia with clozapine. Am. J. Psychiatry 156,
1046–1051.
LaBeaud, A. D., Lisgaris, M. V., King, C. H., and Mandalakas, A. M. (2006).
Pediatric West Nile virus infection: neurologic disease presentations during the
2002 epidemic in Cuyahoga County, Ohio. Pediatr. Infect. Dis. J. 25, 751–753.
doi: 10.1097/01.inf.0000227830.73271.65
Madden, K. (2003). West Nile virus infection and its neurological manifestations.
Clin. Med. Res. 1, 145–150. doi: 10.3121/cmr.1.2.145
McBride, W., Gill, K. R., and Wiviott, L. (2006). West Nile Virus infection
with hearing loss. J. Infect. 53, e203–e205. doi: 10.1016/j.jinf.2006.
01.017
McKinney, R. W., Berge, T. O., Sawyer, W. D., Tigertt, W. D., and Crozier, D.
(1963). Use of an attenuated strain of Venezuelan equine encephalomyelitis
virus for immunization in man. Am. J. Trop. Med. Hyg. 12, 597–603.
Meyer, K. F., Haring, C. M., and Howitt, B. (1931). The etiology of epizootic
encephalomyelitis of horses in the San Joaquin valley, 1930. Science 74, 227–228.
doi: 10.1126/science.74.1913.227
Morjaria, S., Arguello, E., Taur, Y., Sepkowitz, K., Hatzoglou, V., Nemade, A., et al.
(2015). West Nile virus central nervous system infection in patients treated with
rituximab: implications for diagnosis and prognosis, with a review of literature.
Open Forum Infect. Dis. 2:ofv136. doi: 10.1093/ofid/ofv136
Mulder, D. W., Parrott, M., and Thaler, M. (1951). Sequelae of western equine
encephalitis. Neurology 1, 318–327. doi: 10.1212/WNL.1.7-8.318
Murray, K. O., Garcia, M. N., Rahbar, M. H., Martinez, D., Khuwaja, S. A., Arafat,
R. R., et al. (2014). Survival analysis, long-term outcomes, and percentage of
recovery up to 8 years post-infection among the Houston West Nile virus
cohort. PLoS ONE 9:e102953. doi: 10.1371/journal.pone.0102953
Nalca, A., Fellows, P. F., and Whitehouse, C. A. (2003). Vaccines and
animal models for arboviral encephalitides. Antiviral Res. 60, 153–174. doi:
10.1016/j.antiviral.2003.08.001
Paessler, S., Aguilar, P., Anishchenko, M., Wang, H. Q., Aronson, J., Campbell, G.,
et al. (2004). The hamster as an animal model for eastern equine encephalitis–
and its use in studies of virus entrance into the brain. J. Infect. Dis. 189,
2072–2076. doi: 10.1086/383246
Paessler, S., Ni, H., Petrakova, O., Fayzulin, R. Z., Yun, N., Anishchenko, M., et al.
(2006). Replication and clearance of Venezuelan equine encephalitis virus from
the brains of animals vaccinated with chimeric SIN/VEE viruses. J. Virol. 80,
2784–2796. doi: 10.1128/JVI.80.6.2784-2796.2006
Paessler, S., Yun, N. E., Judy, B. M., Dziuba, N., Zacks, M. A., Grund,
A. H., et al. (2007). Alpha-beta T cells provide protection against lethal
encephalitis in the murine model of VEEV infection. Virology 367, 307–323.
doi: 10.1016/j.virol.2007.05.041
Palmer, R. J., and Finley, K. H. (1956). Sequelae of encephalitis; report of a study
after the California epidemic. Calif. Med. 84, 98–100.
Patel, H., Sander, B., and Nelder, M. P. (2015). Long-term sequelae of West Nile
virus-related illness: a systematic review. Lancet Infect. Dis. 15, 951–959. doi:
10.1016/S1473-3099(15)00134-6
Pearce, B. D., Hubbard, S., Rivera, H. N., Wilkins, P. P., Fisch, M. C., Hopkins,
M. H., et al. (2013). Toxoplasma gondii exposure affects neural processing speed
as measured by acoustic startle latency in schizophrenia and controls. Schizophr.
Res. 150, 258–261. doi: 10.1016/j.schres.2013.07.028
Rampal, Sharda, M., and Meena, H. (2007). Neurological complications in
Chikungunya fever. J. Assoc. Physicians India 55, 765–769.
Reddy, A. J., Woods, C. W., and Welty-Wolf, K. E. (2008). Eastern equine
encephalitis leading to multi-organ failure and sepsis. J. Clin. Virol. 42, 418–421.
doi: 10.1016/j.jcv.2008.03.008
Rich, B. A., Vinton, D., Grillon, C., Bhangoo, R. K., and Leibenluft, E. (2005).
An investigation of prepulse inhibition in pediatric bipolar disorder. Bipolar
Disord. 7, 198–203. doi: 10.1111/j.1399-5618.2005.00183.x
Rivas, F., Diaz, L. A., Cardenas, V. M., Daza, E., Bruzon, L., Alcala, A., et al.
(1997). Epidemic Venezuelan equine encephalitis in La Guajira, Colombia,
1995. J. Infect. Dis. 175, 828–832.
Frontiers in Microbiology | www.frontiersin.org 9 June 2016 | Volume 7 | Article 959
fmicb-07-00959 June 16, 2016 Time: 13:1 # 10
Ronca et al. Alphavirus Sequelae
Rogers, D. C., Fisher, E. M. C., Brown, S. D. M., Peters, J., Hunter, A. J., and Martin,
J. E. (1997). Behavioral and functional analysis of mouse phenotype: SHIRPA, a
proposed protocol for comprehensive phenotype assessment. Mamm. Genome
8, 711–713. doi: 10.1007/s003359900551
Silverman, M. A., Misasi, J., Smole, S., Feldman, H. A., Cohen, A. B., Santagata, S.,
et al. (2013). Eastern equine encephalitis in children, Massachusetts and
New Hampshire, USA, 1970–2010. Emerg. Infect. Dis. 19, 194–201. doi:
10.3201/eid1902.120039
Steele, K. E., and Twenhafel, N. A. (2010). REVIEW PAPER: pathology of
animal models of alphavirus encephalitis. Vet. Pathol. 47, 790–805. doi:
10.1177/0300985810372508
Suarez, O. M., and Bergold, G. H. (1968). Investigations of an outbreak of
Venezuelan equine encephalitis in towns of eastern Venezuela. Am. J. Trop.
Med. Hyg. 17, 875–880.
Swerdlow, N. R., Braff, D. L., and Geyer, M. A. (1999). Cross-species studies of
sensorimotor gating of the startle reflex. Ann. N. Y. Acad. Sci. 877, 202–216.
doi: 10.1111/j.1749-6632.1999.tb09269.x
Swerdlow, N. R., Geyer, M. A., and Braff, D. L. (2001). Neural circuit
regulation of prepulse inhibition of startle in the rat: current knowledge
and future challenges. Psychopharmacology (Berl.) 156, 194–215. doi:
10.1007/s002130100799
Taylor, K., Borisevich, V., Kolokoltsova, O., Smith, J., Smith, J., Estes, M., et al.
(2011). Identification of novel immune factors regulating outcome to viral
encephalitis. J. Immun. 186(Supp. 1), 170.12.
Taylor, K., Kolokoltsova, O., Patterson, M., Poussard, A., Smith, J., Estes, D. M.,
et al. (2012). Natural killer cell mediated pathogenesis determines outcome
of central nervous system infection with Venezuelan equine encephalitis
virus in C3H/HeN mice. Vaccine 30, 4095–4105. doi: 10.1016/j.vaccine.2012.
03.076
Tenbroeck, C., and Merrill, M. H. (1933). A serological difference between eastern
and western equine encephalomyelitis virus. Proc. Soc. Exp. Biol. Med. 31,
217–220. doi: 10.3181/00379727-31-7066C
Tigertt, W. D., Berge, T. O., and Downs, W. G. (1962). Studies on
the virus of Venezuelan equine encephalomyelitis in Trinidad, W.I. II.
Serological status of human beings, 1954-1958. Am. J. Trop. Med. Hyg. 11,
835–840.
Villari, P., Spielman, A., Komar, N., McDowell, M., and Timperi, R. J. (1995). The
economic burden imposed by a residual case of eastern encephalitis. Am. J.
Trop. Med. Hyg. 52, 8–13.
Voss, K., Amaya, M., Mueller, C., Roberts, B., Kehn-Hall, K., Bailey, C., et al.
(2014). Inhibition of host extracellular signal-regulated kinase (ERK) activation
decreases new world alphavirus multiplication in infected cells. Virology 46,
490–503. doi: 10.1016/j.virol.2014.09.005
Weatherhead, J. E., Miller, V. E., Garcia, M. N., Hasbun, R., Salazar, L., Dimachkie,
M. M., et al. (2015). Long-term neurological outcomes in West Nile virus-
infected patients: an observational study. Am. J. Trop. Med. Hyg. 92, 1006–1012.
doi: 10.4269/ajtmh.14-0616
Weike, A. I., Bauer, U., and Hamm, A. O. (2000). Effective neuroleptic medication
removes prepulse inhibition deficits in schizophrenia patients. Biol. Psychiatry
47, 61–70. doi: 10.1016/S0006-3223(99)00229-2
White, D. P., Miller, F., and Erickson, R. W. (1983). Sleep apnea and nocturnal
hypoventilation after western equine encephalitis. Am. Rev. Respir. Dis. 127,
132–133. doi: 10.1164/arrd.1983.127.1.132
Winkelmann, E. R., Luo, H., and Wang, T. (2016). West nile virus infection
in the central nervous system. F1000Res. 5(F1000 Faculty Rev):105. doi:
10.12688/f1000research.7404.1
Yin, Z., Wang, X., Li, L., Li, H., Zhang, X., Li, J., et al. (2015). Neurological sequelae
of hospitalized Japanese encephalitis cases in Gansu province, China. Am. J.
Trop. Med. Hyg. 92, 1125–1129. doi: 10.4269/ajtmh.14-0148
Zacks, M. A., and Paessler, S. (2010). Encephalitic alphaviruses. Vet. Microbiol. 140,
281–286. doi: 10.1016/j.vetmic.2009.08.023
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Ronca, Dineley and Paessler. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 10 June 2016 | Volume 7 | Article 959
